These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

929 related items for PubMed ID: 31165410

  • 1. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R, Zhu J, Chen X, Liu Y, Wang Y, Zhang T.
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [Abstract] [Full Text] [Related]

  • 2. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma.
    Chen R, Lu Y, Zhang Y, He R, Tang F, Yuan W, Li Y, Zhang X.
    Medicine (Baltimore); 2021 Oct 22; 100(42):e27475. PubMed ID: 34678878
    [Abstract] [Full Text] [Related]

  • 3. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
    Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX.
    Cancer Commun (Lond); 2018 May 10; 38(1):21. PubMed ID: 29764487
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z, Zhang Z, Luo J, Li N, Peng X.
    J Cancer Res Clin Oncol; 2019 Jul 10; 145(7):1857-1864. PubMed ID: 31062162
    [Abstract] [Full Text] [Related]

  • 5. Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.
    Kawahira M, Yokota T, Hamauchi S, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.
    Jpn J Clin Oncol; 2017 Aug 01; 47(8):705-712. PubMed ID: 28431119
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The evaluation of adding induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a meta-analysis.
    Tang M, Jia Z, Zhang J.
    Eur Arch Otorhinolaryngol; 2021 May 01; 278(5):1545-1558. PubMed ID: 32700235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
    Tan TH, Soon YY, Cheo T, Ho F, Wong LC, Tey J, Tham IWK.
    Radiother Oncol; 2018 Oct 01; 129(1):10-17. PubMed ID: 29555182
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    Wang BC, Xiao BY, Lin GH, Wang C, Liu Q.
    BMC Cancer; 2020 May 06; 20(1):393. PubMed ID: 32375701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
    Takamizawa S, Honma Y, Murakami N, Mori T, Oka H, Yamamoto S, Kashihara T, Ito K, Kubo Y, Ikeda A, Matsumoto F, Omura G, Kobayashi K, Itami J, Kato K, Yoshimoto S.
    Invest New Drugs; 2021 Apr 06; 39(2):564-570. PubMed ID: 32940872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Li WF, Chen L, Sun Y, Ma J.
    Chin J Cancer; 2016 Nov 15; 35(1):94. PubMed ID: 27846913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.